Google Übersetzer
Alterity Therapeutics Ltd
About
Alterity Therapeutics Ltd (AU:ATH) — investor relations, events, news, and company updates on 6ix.
Latest News
Today
Alterity Therapeutics Releases Appendix 4C – Q3 FY26 Quarterly Cash Flow Report & Corporate Update
Yesterday
Notice of General Meeting/Proxy Form
Apr 27 2026
Alterity Therapeutics Receives Positive FDA Feedback Following Second Type C Meeting on ATH434 Phase 3 Program in Multiple System Atrophy
Apr 27 2026
Alterity Receives Positive FDA Feedback on CMC Meeting
Apr 22 2026
Alterity Therapeutics Presents New Analysis of ATH434 Phase 2 Trial Data in Late Breaking Science Session of the American Academy of Neurology
Financials
Revenue
A$6.64 M
Market Cap
A$97.88 M
EPS
0.00